South and Central America Percutaneous Mechanical Circulatory Support Devices Market Size by 2027

South and Central America Percutaneous Mechanical Circulatory Support Devices Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product (Intra-Aortic Balloon Pumps, VA-Extracorporeal Membrane Oxygenators (ECMO), and Short-Term Ventricular Assist Devices); End User (Hospitals, Ambulatory Surgical Centers, and Others); and Country

Historic Data: 2017-2018 | Base Year: 2019 | Forecast Period: 2020-2027
  • Status : Published
  • Report Code : TIPRE00018226
  • Category : Life Sciences
  • No. of Pages : 95
  • Available Report Formats : pdf-format excel-format
  • Last update date : February 05, 2021
South and Central America Percutaneous Mechanical Circulatory Support Devices Market Size by 2027
Report Date: February 05, 2021   |   Report Code: TIPRE00018226 Email: sales@theinsightpartners.com

2019 Market Size

US$ 50.10 Mn

Base year value

2027 Forecast

US$ 122.51 Mn

Projected by 2027

CAGR 2020-2027

12.1 %

Growth rate

Addressable Market

US$ 693.30 Mn

(2020-2027)

The South & Central America percutaneous mechanical circulatory support devices market is expected to reach US$ 122.51 million by 2027 from US$ 50.10 million in 2019; it is estimated to grow at a CAGR of 12.1% from 2020 to 2027.

The rising geriatric population, and increasing prevalence of cardiovascular diseases are the key factors driving the growth of percutaneous mechanical circulatory support devices. However, high costs of these devices and procedures associated with them, and impact of COVID-19 pandemic on medical device industry is the major factor hindering the Percutaneous mechanical circulatory support devices market growth in South & Central America.

Percutaneous mechanical circulatory support devices offer an effective and rapid approach to slow the downward spiral of hemodynamic instability among patients suffering with decompensated heart failures and cardiogenic shocks till a more definitive strategy is perceived among patients to recover from these cardiac ailments. The major roles of the percutaneous mechanical circulatory support devices include improving the native cardiac output, reducing ventricular volume and filling pressures, augmenting coronary perfusion, and maintaining vital organ perfusion.

The developed countries depend on a healthcare model in which healthcare professions treat medical conditions with the help of medications and surgeries. However, in developing countries, more focus is on holistic and conventional treatment methods on a large scale. Major differences between developed and developing countries are resources like money, infrastructure, skilled workforce, education, and products. Healthcare in developing countries is undergoing rapid changes. The healthcare systems in those countries are facing challenges such as the burden of rising and aging populations, and with it, the delivery of adequate healthcare to the masses.

The healthcare infrastructure in large cities of developing countries may have all the necessary amenities, but rural areas may not. Thus, these massive unexplored areas pose as ample revenue generation opportunities for percutaneous mechanical circulatory support devices market, as cardiovascular diseases are among the prominently prevalent health conditions within these economies. Countries like Brazil and Argentina have a large patient population base, and the healthcare expenditure is increasing, thus illustrating immense healthcare market potential. Thus, with the growing healthcare industry and increasing government initiatives, the demand for percutaneous mechanical circulatory support devices is expected to increase in the developing economies.

Covid-19 pandemic is making its way to all South & Central America countries. In Brazil, the number of confirmed cases are 79,400 with 5,500 reported death. With the growing number of surgeries, Brazil government has taken initiative to support healthcare professional. For instance, as per the Health Ministry, Brazil’s government has distributed over 14.2 million surgical masks national wide to prevent the growing number of COVID-19 cases. These regions are facing huge problem, as they are low-cost regions. Additionally, these regions are known for its medical tourism industry, however, due to COVID-19 the Brazil have restricted travelling that has significantly affected the medical tourism industry. Additionally, increasing ill patients in low-cost regions are more prone to death by COVID-19 as healthcare professionals have limited their checking of patients.

Rest of South & Central America Percutaneous Mechanical Circulatory Support Devices Market, Revenue and Forecast to 2027 (US$ Mn)

Rest of South & Central America Percutaneous Mechanical Circulatory Support Devices Market, Revenue and Forecast to 2027 (US$ Mn)
  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

SOUTH & CENTRAL AMERICA PERCUTANEOUS MECHANICAL CIRCULATORY SUPPORT DEVICES MARKET SEGMENTATION

By Product

  • Intra-Aortic Balloon Pumps
  • VA-Extracorporeal Membrane Oxygenation (ECMO)
  • Short-Term Ventricular Assist Devices (VADs)
    • Impella
    • Tandem Heart

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Country

  • Brazil
  • Argentina

Company Profiles

  • Abbott
  • Livanova Plc (Cardiacassist, Inc)
  • Eurosets
  • Berlin Heart
  • Medtronic

South and Central America Percutaneous Mechanical Circulatory Support Devices Report Scope

Report Attribute Details
Market size in 2019 US$ 50.10 Million
Market Size by 2027 US$ 122.51 Million
CAGR (2020 - 2027) 12.1%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Product
  • Intra-Aortic Balloon Pumps
  • VA-Extracorporeal Membrane Oxygenators
  • Short-Term Ventricular Assist Devices
By End User
  • Hospitals
  • Ambulatory Surgical Centers
Regions and Countries Covered South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Market leaders and key company profiles
  • Abbott
  • Livanova Plc (Cardiacassist, Inc)
  • Eurosets
  • Berlin Heart
  • Medtronic
Trupti Wadekar
Assistant Manager,
Market Research & Consulting

Trupti is a senior consultant with over 10 years of experience in the Healthcare sector, specializing in pharmaceuticals, biotechnology, and life-sciences markets. She holds a Bachelor’s degree in Biotechnology and an MBA with dual specialization in Marketing and Pharmaceuticals & Biotechnology, combining a strong scientific foundation with a strategic and commercial perspective. Her professional experience encompasses market research, competitive intelligence, strategic advisory, and business development, supporting clients across diverse and evolving healthcare markets.

She has worked extensively on market sizing and assessment, growth strategy, market expansion, and strategic decision-making initiatives, helping clients identify opportunities and address complex business challenges. Trupti brings strong expertise in client engagement, stakeholder management, team leadership, and translating research findings into actionable business insights. Her ability to connect scientific understanding with market dynamics and commercial strategy enables her to deliver practical, high-impact solutions aligned with client objectives.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA